Adapting to the World’s Exploding Need for Bandwidth

 

On this episode of Test Your Network, an EXFO podcast, host Tyler Kern was joined by EXFO Director, Transport and Datacom Business Unit Sophie Legault and Xilinx Director of Wired Communications Gilles Garcia for a discussion about how the two companies are working to provide boosted connectivity during a time when remote-work requirements and more have thrust a need for that connectivity into the forefront.

EXFO develops test, monitoring and analytics solutions for network operators, helping them ensure they’re performing to the best of their ability at all times through robust testing, real-time data and more, while Xilinx delivers adaptable communications platforms for wired and wireless networks that help ensure reliable performance.

The two companies have partnered together to provide fully formed solutions that have been tested and demonstrated, giving end users confidence in their ability to solve the myriad challenges presented by 5G.

“We have been working for years with EXFO, and EXFO is using a lot of the Xilinx technology in their products, as well. … It’s almost a ripple effect,” Garcia said. “When we are bringing the new chips to the market, we need to work very closely with EXFO in order to have (interoperability) between our platforms and their testing equipment, so we can prove to the world that, in fact, the test equipment is ready.”

With the COVID-19 pandemic still causing ripple effects throughout the world’s industries, the need for flexibility and performance in 5G solutions is more apparent than ever before.

Fortunately, new innovations are helping 4G and 5G coexist and pushing the 5G rollout forward.

“If we look more specifically at the 5G transport, to bring all the new applications that are promised by 5G, there are quite a number of new technologies that are planned to be deployed in the transport network, or what we call the crosshaul transport network. … There are very strict requirements on that network for things like latency, throughput, network slicing and others,” Legault said.

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More